Literature DB >> 1595997

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

P W Jones1, F H Quirk, C M Baveystock, P Littlejohns.   

Abstract

A need was identified for a fixed-format self-complete questionnaire for measuring health in chronic airflow limitation. A 76-item questionnaire was developed, the St. George's Respiratory Questionnaire (SGRQ). Three component scores were calculated: symptoms, activity, and impacts (on daily life), and a total score. Three studies were performed. (1) Repeatability was tested over 2 wk in 40 stable asthmatic patients and 20 patients with stable COPD. The coefficient of variation for the SGRQ total score was 19%. (2) SGRQ scores were compared with spirometry, 6-min walking distance (6-MWD), MRC respiratory symptoms questionnaire, anxiety, depression, and general health measured using the Sickness Impact Profile score. A total of 141 patients were studied, mean age 63 yr (range 31 to 75) and prebronchodilator FEV1, 47% (range 11 to 114%). SGRQ scores correlated with appropriate comparison measures. For example, symptom score versus frequency of wheeze, r2 = 0.32, p less than 0.0001; activity versus 6-MWD, r2 = 0.50, p less than 0.0001; impact versus anxiety, r2 = 0.38, p less than 0.0001. Multivariate analysis demonstrated that SGRQ scores summed a number of areas of disease activity. (3) Changes in SGRQ scores and other measures were studied over 1 yr in 133 patients. Significant correlations were found between changes in SGRQ scores and the comparison measures (minimum r2 greater than 0.05, p less than 0.01). Multivariate analysis showed that change in total SGRQ score summed changes in a number of aspects of disease activity. We conclude that the SGRQ is a valid measure of impaired health in diseases of chronic airflow limitation that is repeatable and sensitive.

Entities:  

Mesh:

Year:  1992        PMID: 1595997     DOI: 10.1164/ajrccm/145.6.1321

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  807 in total

Review 1.  Gender differences in airway behaviour over the human life span.

Authors:  M R Becklake; F Kauffmann
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

2.  A new tool for monitoring asthma outcomes: the ITG Asthma Short Form.

Authors:  M S Bayliss; D M Espindle; D Buchner; M S Blaiss; J E Ware
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 3.  The prediction of benefit from pulmonary rehabilitation: setting, training intensity and the effect of selection by disability.

Authors:  M D Morgan
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

4.  Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.

Authors:  K Stavem
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

Review 5.  Stable chronic obstructive pulmonary disease.

Authors:  H A Kerstjens
Journal:  BMJ       Date:  1999-08-21

6.  Predictive value of a simple asthma morbidity index in a general practice population.

Authors:  K Jones; R Cleary; M Hyland
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

7.  Assessment of dyspnea in asthma: validation of The Dyspnea-12.

Authors:  Janelle Yorke; Anne-Marie Russell; Jeff Swigris; Caroline Shuldham; Carol Haigh; Nikki Rochnia; Jennifer Hoyle; Paul W Jones
Journal:  J Asthma       Date:  2011-06-02       Impact factor: 2.515

8.  GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

Authors:  MeiLan K Han; Hana Muellerova; Douglas Curran-Everett; Mark T Dransfield; George R Washko; Elizabeth A Regan; Russell P Bowler; Terri H Beaty; John E Hokanson; David A Lynch; Paul W Jones; Antonio Anzueto; Fernando J Martinez; James D Crapo; Edwin K Silverman; Barry J Make
Journal:  Lancet Respir Med       Date:  2012-09-03       Impact factor: 30.700

9.  Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.

Authors:  MeiLan K Han; Nabihah Tayob; Susan Murray; Mark T Dransfield; George Washko; Paul D Scanlon; Gerard J Criner; Richard Casaburi; John Connett; Stephen C Lazarus; Richard Albert; Prescott Woodruff; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

10.  Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.

Authors:  Hironi Makita; Yasuyuki Nasuhara; Katsura Nagai; Yoko Ito; Masaru Hasegawa; Tomoko Betsuyaku; Yuya Onodera; Nobuyuki Hizawa; Masaharu Nishimura
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.